Search
RCT1100
go.drugbank.com/drugs/DB18830InvestigationalRCT1100 is an investigational mRNA-based therapeutic that aims to treat primary ciliary dyskinesia caused by pathogenic mutations in DNAI1.[L50788]
Borage oil
go.drugbank.com/drugs/DB11238ApprovedBorage oil is used as an herbal treatment of skin disorders including eczema, seborrheic dermatitis, and neurodermatitis as well as other inflammatory, cardiovascular and endocrine disorders, although
TC-2216
go.drugbank.com/drugs/DB06044InvestigationalTC-2216 is an investigational novel small molecule that is being developed as an oral treatment for depression and anxiety disorders.
Recombinant Bacterial ACE2 Receptors-like Enzyme
go.drugbank.com/drugs/DB15741Investigational._ The molecule, an Angiotensin Converting Enzyme 2 (ACE2)-like enzyme, shares structural similarities to the mammalian ACE2. B38-CAP is an ACE2-like enzyme which decreases angiotensin II levels.
Laquinimod
go.drugbank.com/drugs/DB06685InvestigationalLaquinimod is an immunomodulator developed by Active Biotech and produced by Teva Pharmaceutical Industries. … It is currently under development in phase III trials for treatment of multiple sclerosis as an oral therapy, like fingolimod.
Imnopitant
go.drugbank.com/drugs/DB21456ExperimentalImnopitant has a monoisotopic molecular weight of 550.22 Da.
Libvatrep
go.drugbank.com/drugs/DB21488ExperimentalLibvatrep has a monoisotopic molecular weight of 305.12 Da.
Telmapitant
go.drugbank.com/drugs/DB20768ExperimentalTelmapitant has a monoisotopic molecular weight of 515.16 Da.
Cintirorgon
go.drugbank.com/drugs/DB20916InvestigationalCintirorgon has a monoisotopic molecular weight of 603.12 Da.
Dapitant
go.drugbank.com/drugs/DB20991ExperimentalDapitant has a monoisotopic molecular weight of 561.29 Da.